US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (221)
  • Diseases & Conditions (4420)
  • Drug Delivery (185)
  • Therapeutic Area (7002)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cardiac Rhythm Management Device Markets
5/1/2015 | published by: Kalorama Information
... particularly arrhythmias and congestive heart failure. This report,  C ardiac Rhythm Device Markets,  includes cardiac rhythm management devices with both external and internal applications.  Major segments include defibrillators: electrical devices that deliver therapeutic levels of ...  |  read more...
USD 3,995
Gram-Negative Bacterial Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gram-Negative Bacterial Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Grass Pollen Allergy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Grass Pollen Allergy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Growth Hormone Deficiency-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Growth Hormone Deficiency Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Guillain-Barre Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Guillain-Barre Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Guillain-Barre Syndrome- Pipeline ...  |  read more...
USD 1,250
Gynecological Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gynecological Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gynecological Cancer- Pipeline ...  |  read more...
USD 1,250
H3N2 Infection-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The H3N2 Infection Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, H3N2 Infection- Pipeline ...  |  read more...
USD 1,250
Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Cancer Squamous Cell Carcinoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Head And Neck Cancer Squamous Cell Carcinoma Report helps to ...  |  read more...
USD 1,250
Helicobacter Pylori Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Helicobacter Pylori Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Matrix Metalloproteinase 12 (MMP-12 or Macrophage ...  |  read more...
USD 1,250
Hemophilia A-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemophilia A Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemophilia A- Pipeline ...  |  read more...
USD 1,250
Maturation Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Maturation Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Maturation Inhibitors- ...  |  read more...
USD 1,250
Hemophilia B-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemophilia B Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemophilia B- Pipeline ...  |  read more...
USD 1,250
Hemorrhagic Fever-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemorrhagic Fever Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemorrhagic Fever- Pipeline ...  |  read more...
USD 1,250
Hemorrhagic Shock-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemorrhagic Shock Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hemorrhagic Shock- Pipeline ...  |  read more...
USD 1,250
Hepatic - Colorectal Metastasis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatic - Colorectal Metastasis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Hepatic (Liver) Tumor-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatic (Liver) Tumor Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Hepatic Edema-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatic Edema Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hepatic Edema- Pipeline ...  |  read more...
USD 1,250
Hepatitis A-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatitis A Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hepatitis A- Pipeline ...  |  read more...
USD 1,250
Hereditary Angioedema (HAE)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hereditary Angioedema (HAE) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Herpes Simplex Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Herpes Simplex Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Herpes Zoster (Shingles)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Herpes Zoster (Shingles) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Herpetic Keratitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Herpetic Keratitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Herpetic Keratitis- Pipeline ...  |  read more...
USD 1,250
High Triglyceridemia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The High Triglyceridemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, High Triglyceridemia- Pipeline ...  |  read more...
USD 1,250
Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10